Role of allogeneic transplantation in chronic myeloid leukemia.

Expert review of hematology

Volumn 1, Issue 1, 2008, Pages 41-50

  Heim, Dominik ^a   Gratwohl, Alois ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMATINIB; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ALLOTRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL (TOPIC); DRUG RESISTANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; RECURRENT DISEASE; REVIEW; RISK FACTOR;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; DRUG RESISTANCE, NEOPLASM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PIPERAZINES; PYRIMIDINES; RECURRENCE; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 79954446595     PISSN: None     EISSN: 17474094     Source Type: Journal    
DOI: 10.1586/17474086.1.1.41     Document Type: Review

References (0)